Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis-Reference-Cited by-同舟云学术

Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis

Published:2017-04-03 Issue:12 Volume:31 Page:2709-2716
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Maekawa T,Osawa Y,Izumi T,Nagao S,Takano K,Okada Y,Tachi N,Teramoto M,Kawamura T,Horiuchi T,Saga R,Kato S,Yamamura T,Watanabe J,Kobayashi A,Kobayashi S,Sato K,Hashimoto M,Suzu S,Kimura F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu2017112.pdf

Reference38 articles.

1. Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 2014; 28: 1472–1477.

2. Hitchcock IS, Kaushansky K . Thrombopoietin from beginning to end. Br J Haematol 2014; 165: 259–268.

3. Ku H, Yonemura Y, Kaushansky K, Ogawa M . Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996; 87: 4544–4551.

4. Yan XQ, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y et al. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995; 86: 4025–4033.

5. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA et al. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 1997; 90: 4369–4383.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy;European Journal of Clinical Investigation;2024-08-08

2. Inflammation and bone marrow fibrosis: novel immunotherapeutic targets;Current Opinion in Hematology;2023-08-02

3. Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model;Leukemia;2023-03-16

4. Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients;Leukemia;2022-12-05

5. TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche;Journal of Clinical Investigation;2022-06-01